Planet 13 Holdings (PLNH) Accumulated Expenses (2021 - 2026)
Planet 13 Holdings' (PLNH) quarterly Accumulated Expenses came in at $3.3 million in Q1 2026, down 55.78% year-on-year from $7.4 million in Q1 2025, and down 29.62% on a QoQ basis from $4.6 million in Q4 2025.
Planet 13 Holdings (PLNH) Accumulated Expenses (2021 - 2026) Analysis & Trends
Planet 13 Holdings (PLNH) has 6 years of Accumulated Expenses data on file, last reported at $3.3 million in Q1 2026.
- On a quarterly basis, Accumulated Expenses fell 55.78% year-over-year to $3.3 million in Q1 2026; TTM through Mar 2026 was $3.3 million, a 55.78% decrease from a year earlier, with the FY2025 full-year figure at $4.6 million, down 36.42% from the prior year.
- Accumulated Expenses for Q1 2026 stood at $3.3 million, down from $4.6 million in the prior quarter.
- Over the last five years, Accumulated Expenses for PLNH reached as high as $10.6 million in Q3 2024 and fell as low as $3.3 million in Q1 2026.
- Historically, Accumulated Expenses has averaged $6.8 million across 5 years, with a median of $7.0 million in 2023.
- Across the five-year window, Accumulated Expenses surged 67.06% in 2024 and plunged 55.78% in 2026, its largest moves.
- Year by year, Accumulated Expenses stood at $8.1 million in 2022, then retreated by 24.46% to $6.1 million in 2023, then climbed by 19.48% to $7.3 million in 2024, then plunged by 36.42% to $4.6 million in 2025, then declined by 29.62% to $3.3 million in 2026.
- Per Business Quant data, the three most recent Accumulated Expenses figures were $3.3 million in Q1 2026, $4.6 million in Q4 2025, and $7.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Planet 13 Holdings | 39.35 Mn | 23.09 Mn | 9.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.26 Mn |
| Dec 31, 2025 | 4.63 Mn |
| Sep 30, 2025 | 7.28 Mn |
| Jun 30, 2025 | 7.69 Mn |
| Mar 31, 2025 | 7.37 Mn |
| Dec 31, 2024 | 7.29 Mn |
| Sep 30, 2024 | 10.55 Mn |
| Jun 30, 2024 | 8.91 Mn |
| Mar 31, 2024 | 5.19 Mn |
| Dec 31, 2023 | 6.10 Mn |
| Sep 30, 2023 | 6.32 Mn |
| Jun 30, 2023 | 6.99 Mn |
| Mar 31, 2023 | 6.54 Mn |
| Dec 31, 2022 | 8.07 Mn |
| Sep 30, 2022 | 5.99 Mn |
| Dec 31, 2021 | 7.03 Mn |